3 Neil Woodford High Yield Picks: GlaxoSmithKline plc, Centrica PLC And Legal & General Group Plc

GlaxoSmithKline plc (LON:GSK), Centrica PLC (LON:CNA) and Legal & General Group Plc (LON:LGEN) are the master investor’s top high-yield blue chips.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Are you looking for outstanding dividend picks in the market’s end-of-summer sale? Look no further than the top yielders among the blue-chip holdings of renowned fund manager Neil Woodford.

Right now, Woodford favourites GlaxoSmithKline (LSE: GSK), Centrica (LSE: CNA) and Legal & General (LSE: LGEN) are all offering yields in excess of 5% — well above the FTSE 100 average.

  Recent
share price
12-month
forecast yield
GlaxoSmithKline 1,310p 6.1%
Legal & General 249p 5.6%
Centrica 236p 5.2%

GlaxoSmithKline

GlaxoSmithKline has suffered in recent years from the unwelcome effects of expiring patents on some of its top-selling products. However, the Footsie’s biggest pharmaceuticals’ firm is nearing the end of what will be a four-year run of earnings falls, because earnings growth is forecast to return in 2016.

Glaxo has said it intends to peg the annual dividend at 80p a year through to 2017, giving a 6.1% annual income for the period. (There’ll also be a little extra from a one-off special dividend of 20p that’s planned to be paid alongside the 2015 Q4 payout.) Dividend increases should be able to resume after 2017, if Glaxo’s guidance of mid-to-high single digits earnings growth is on the mark.

Woodford considers Glaxo a core income stock. Also, the market’s focus on short-term earnings in recent years has put the shares at a discount to a sum-of-the-parts valuation of the group, giving good scope for share price appreciation in the future.

Centrica

Centrica — the owner of British Gas — is another blue-chip company that is going through a phase of earnings declines. Unseasonable weather hurt the company last year, while low oil and gas prices are impacting on the group’s upstream business this year.

Under a new chief executive, Centrica announced earlier this year that it was “rebasing” its dividend 30% lower (a move Woodford didn’t think was entirely necessary). Despite the cut, the yield has risen to 5.2%, because the shares have fallen, with the market not being enamoured by the short-term outlook of a 7% earnings decline this year and meagre growth of 1% next year.

Centrica’s shares are now trading at a multi-year low, so investors today are getting a better dividend yield than Woodford was able to secure on purchases he made last year and earlier this year.

Legal & General

Legal & General has no earnings worries. The insurer and asset manager has been posting double-digit annual growth in recent years, and is set to continue doing so for the foreseeable future. The dividend has increased faster than earnings since the financial crisis, because management decided to gradually lower cover as recovery gained momentum.

The dividend should now start to move in step with earnings. But who can complain when there’s currently a 5.6% starting yield and the prospect of dividend increases tracking double-digit earnings growth? Not Woodford. Legal & General is the only FTSE 100 financial stock he considers worthy of holding.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended Centrica and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »